{"title":"Recosyn","description":"\u003cdiv class=\"snocks-manual-grid\"\u003e\n\u003cdiv class=\"snocks-col\"\u003e\n\u003cdiv class=\"snocks-like-block\"\u003e\n\u003ch3\u003eBuy Recosyn\u003c\/h3\u003e\n\u003cp\u003eThose who want to \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-m-d-n-1-x-1-ml\"\u003ebuy Recosyn\u003c\/a\u003e are usually looking for a hyaluronic acid injection for intraarticular use in osteoarthritis and other degenerative joint conditions. The Recosyn product family includes several variants with different fill volumes, concentrations, and treatment concepts. At StakonMed, you will find the Recosyn range clearly presented in one place and can specifically choose between \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-m-d-n-1-x-1-ml\"\u003eRecosyn m.d. N\u003c\/a\u003e, \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-20-1-x-2-ml\"\u003eRecosyn 20\u003c\/a\u003e, \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-forte-n-44-1-x-2-ml\"\u003eRecosyn forte N 44\u003c\/a\u003e, \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-max-forte-n-1-x-2-ml\"\u003eRecosyn Max forte N\u003c\/a\u003e, and \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-uno-ultra-1-x-4-8-ml\"\u003eRecosyn Uno Ultra\u003c\/a\u003e. This is especially helpful for doctors, clinics, and informed self-payers because it allows a direct comparison of the different Recosyn joint injections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"snocks-like-block\"\u003e\n\u003ch3\u003eWhat is Recosyn?\u003c\/h3\u003e\n\u003cp\u003eRecosyn is a product line containing sodium hyaluronate for intraarticular injection into the joint. Hyaluronic acid is a natural component of synovial fluid and contributes to viscoelasticity, lubrication, and shock absorption there. This is exactly where Recosyn acts. The preparations are intended for complaints and movement restrictions in degenerative joint changes, especially in osteoarthritis of the knee joint and other synovial joints. Those searching for terms like Recosyn hyaluron, Recosyn osteoarthritis, Recosyn knee, or Recosyn injection usually mean this type of medical joint treatment. The hyaluronic acid contained in the Recosyn range is produced by bacterial fermentation. The products are sterile, intended for single use, and exclusively for application by physicians.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"snocks-like-block\"\u003e\n\u003ch3\u003eWhat Recosyn variants are available?\u003c\/h3\u003e\n\u003cp\u003eThe Recosyn range includes several versions for different needs. \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-m-d-n-1-x-1-ml\"\u003eRecosyn m.d. N 1 x 1.0 ml\u003c\/a\u003e contains 10 mg sodium hyaluronate per 1 ml. \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-20-1-x-2-ml\"\u003eRecosyn 20 1 x 2.0 ml\u003c\/a\u003e is a classic Recosyn variant with a 2 ml prefilled syringe and 1 percent sodium hyaluronate. \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-forte-n-44-1-x-2-ml\"\u003eRecosyn forte N 44 1 x 2.0 ml\u003c\/a\u003e contains 44 mg sodium hyaluronate per prefilled syringe and is thus more concentrated. \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-max-forte-n-1-x-2-ml\"\u003eRecosyn Max forte N 1 x 2.0 ml\u003c\/a\u003e combines 44 mg sodium hyaluronate additionally with niacinamide. \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-uno-ultra-1-x-4-8-ml\"\u003eRecosyn Uno Ultra 1 x 4.8 ml\u003c\/a\u003e is designed as a larger single-use syringe. Especially when specifically searching for Recosyn forte, Recosyn Max forte, or Recosyn Uno Ultra, it is worthwhile to take a close look at volume, composition, and intended use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"snocks-col\"\u003e\n\u003cdiv class=\"snocks-like-block\"\u003e\n\u003ch3\u003eRecosyn for osteoarthritis\u003c\/h3\u003e\n\u003cp\u003eRecosyn is used for pain and limited joint mobility in the context of degenerative changes. Searches for Recosyn in knee osteoarthritis are particularly common. This also fits the typical application, as several products in the range are intended for symptomatic osteoarthritis of the knee joint or are generally described for degenerative changes of the knee joint and other synovial joints. Those who want to buy Recosyn for osteoarthritis should always keep in mind that the selection of the appropriate preparation must be made by a physician. The diagnosis, affected joint, desired treatment scheme, and the assessment of the treating doctor are decisive. Recosyn is not an injection for self-administration but a medical device for intraarticular injection by trained medical professionals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"snocks-like-block\"\u003e\n\u003ch3\u003eHow is Recosyn used?\u003c\/h3\u003e\n\u003cp\u003eThe use of Recosyn depends on the respective variant. Some preparations are intended for multiple injections at fixed intervals, others rather for single use. According to product information, the beneficial effects of a treatment can last at least up to 6 months depending on the product. At the same time, the treatment scheme differs within the Recosyn family. Therefore, it makes sense to look directly at the respective product page before choosing, for example, \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-20-1-x-2-ml\"\u003eRecosyn 20\u003c\/a\u003e for classic multiple applications, \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-forte-n-44-1-x-2-ml\"\u003eRecosyn forte N 44\u003c\/a\u003e for more concentrated 2 ml variants, or \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-uno-ultra-1-x-4-8-ml\"\u003eRecosyn Uno Ultra\u003c\/a\u003e for a different injection concept. After treatment, it is typically recommended to rest the joint temporarily and cool it if necessary. Storage should be dry, protected from light, and between 2 and 25 degrees Celsius.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"snocks-like-block\"\u003e\n\u003ch3\u003eOrder Recosyn online at StakonMed\u003c\/h3\u003e\n\u003cp\u003eIf you want to order Recosyn online, you will find the most important variants of the brand in one place at StakonMed. This not only improves clarity but also the comparability of the individual Recosyn products. You get a quick overview of fill volume, concentration, and product differences and can go directly to the appropriate detail page. For a targeted start, you can directly access \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-m-d-n-1-x-1-ml\"\u003eRecosyn m.d. N\u003c\/a\u003e, \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-max-forte-n-1-x-2-ml\"\u003eRecosyn Max forte N\u003c\/a\u003e, or \u003ca href=\"https:\/\/stakonmed.de\/products\/recosyn-uno-ultra-1-x-4-8-ml\"\u003eRecosyn Uno Ultra\u003c\/a\u003e. This way, the suitable Recosyn joint injection is quickly found.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","products":[{"product_id":"recosyn-m-d-n-1-x-1-ml","title":"Recosyn m.d.N  1x 1.0 ml","description":"\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/stakonmed.de\/collections\/recosyn\" title=\"Recosyn | Gelenkspritzen | StakonMed\"\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003c\/a\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003em.d. N\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSodium hyaluronate intra-articular\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDescription\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product contains a prefilled syringe with hydrogel made from highly purified sodium hyaluronate obtained by bacterial fermentation without genetic modifications, with high molecular weight, used to improve viscosity in intra-articular connective tissue. It has undergone steam sterilization for injectable products and is non-pyrogenic.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product contains 1 ml aqueous, physiological phosphate buffer solution with 10 mg sodium \u003c\/span\u003e\u003cspan\u003ehyaluronate. The sodium hyaluronate hydrogel is in a weak, sterile \u003c\/span\u003e\u003cspan\u003elen, isotonic and apyrogenic phosphate-buffered saline solution with a pH of 7.2 (6.8 – 7.4) in sufficient volume for injection. The fill volume of a prefilled syringe is 1 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe chemical components are listed in the table on the right (weight per volume as mg substance per 1 ml hydrogel).\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eProperties and mode of action\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eEssential component of healthy synovial fluid is the widespread glycosami\u003c\/span\u003e\u003cspan\u003enoglycan hyaluronic acid. This natural biopolymer provides viscoelasticity and, thanks to its lubricating and shock-absorbing properties, enables pain-free physiological movements; it also supplies nutrients to the cartilage. The \u003c\/span\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003em.d. N \u003c\/span\u003e\u003cspan\u003econtained sodium hyaluronate is a salt of hyaluronic acid.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eIndications\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePain and limitation of joint mobility in degenerative changes of the knee joint and other synovial joints, including osteoarthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eContraindications\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used in patients\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with known hypersensitivity to any of the ingredients\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with inflammation in the joint\u003cbr\u003e- with septic arthritis\u003cbr\u003e- with skin infections or skin diseases in the injection area\u003cbr\u003e- with natural or medication-induced coagulation disorders such as hemophilia\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eor when using anticoagulants such as Marcumar (phenprocoumon) or Coumadin (warfarin)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSince there are no clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, use in these patients is not recommended.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePrecautions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eSince septic arthritis can be a serious complication of treatment, please observe all precautions usually necessary for surgical procedures. Injections of the hydrogel must be administered precisely into the joint cavity; injections into blood vessels and surrounding tissue must be avoided.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use if the prefilled syringe or sterile packaging is damaged.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe opened product must not be resterilized, resealed, or reused. It is intended for use by a single patient at a single treatment session.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePossible side effects\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo adverse effects were observed in biocompatibility tests with the product. Local reactions such as pain, redness, warmth, and swelling may occur in the treated joint. These symptoms can be reduced by cooling the treated area with an ice pack for 5 to 10 minutes after injection. During the first days of treatment, the simultaneous oral intake of pain and anti-inflammatory medications (NSAIDs) may be beneficial. If severe pain or inflammation occurs, treatment should be discontinued. Management of adverse reactions should only be carried out under the supervision of the treating physician. Immediately after the injection, strenuous physical activity should be avoided, and other instructions from the doctor should be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMedical professionals should inform the patient\u003cbr\u003e- about possible adverse events related to the product.\u003cbr\u003e- that the patient must inform a doctor of any adverse event or complication.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePharmacological and chemical interactions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSo far, there are no data on the incompatibility of the product with other solutions for intra-articular use.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThere is a chemical incompatibility between sodium hyaluronate and quaternary ammonium compounds such as benzalkonium chloride, which can lead to crystalline precipitation. Therefore, this product must never come into contact with surgical instruments or other products containing these compounds, or with solutions rinsed with quaternary ammonium compounds used as biocidal preservatives.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDosage, type, and duration of use\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRemove the prefilled syringe from its packaging. Remove the protective cap from the Luer-Lock thread. Screw a suitable sterile injection needle onto the syringe. The use of a single-use needle is recommended. Air should be evacuated from the needle before injection. The skin area intended for injection must be cleaned with an appropriate topical antiseptic. In the case of joint effusion, it is recommended to first reduce the effusion by aspiration before injecting the gel and to examine it for bacterial etiology. The hydrogel can be injected intra-articularly 1 to 5 times at intervals determined by the physician. The beneficial effects of a treatment last at least 6 months. Treatment cycles can be repeated if necessary.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnused product must be disposed of.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage form\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eOne box with a prefilled syringe of 1 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eShelf life\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used after the expiration date. The expiration date (month\/year) is printed on the syringe blister and on the carton.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStorage instructions\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product should be stored dry between 2° and 25°C and protected from light and impact in the original packaging. Accordingly, observe the warning symbols on the packaging.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKeep the product out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eRecommended user group\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eIntended exclusively for use by physicians.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eFor single use only. Do not resterilize. Do not use syringes, needles, or hydrogel from open or damaged packaging or attempt to reseal packaging. Syringe contents are non-toxic and non-flammable.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhen using a product from damaged packaging or reusing it on other patients or the same patient at a different time, the intended properties and sterility are not guaranteed. Otherwise possible \u003c\/span\u003e\u003cspan\u003eTransmission of material contamination and pathogens from the environment, the clinical \u003c\/span\u003e\u003cspan\u003eUse on another area or (other) patients could lead to health complications. Resealing or resterilization does not constitute an allowed or guaranteed restoration of the usable condition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnused syringes and their contents are not infectious and can be disposed of before or after the expiration date, observing national and local regulations. Used syringes and needles must be treated as epidemiologically hazardous waste and national and local regulations for safe use and disposal must be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInformation status 06\/2021\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003cspan style=\"font-size: 0.875rem;\"\u003eIntended exclusively for use by physicians.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Recordati Pharma GmbH","offers":[{"title":"Default Title","offer_id":47355880538452,"sku":"130","price":21.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/recosyn-md-n-recordati-pharma-gmbh-gelenkspritzen-stakonmed-883596.jpg?v=1772215360"},{"product_id":"recosyn-20-1-x-2-ml","title":"Recosyn 20 1x 2.0 ml","description":"\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/stakonmed.de\/collections\/recosyn\" title=\"Recosyn | Joint Injections | StakonMed\"\u003e\u003cspan\u003eRECOSYN\u003c\/span\u003e\u003c\/a\u003e\u003cspan\u003e®\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e1. Intended Use\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis product is a medical device for use in humans and is injected intra-articularly into the knee joint. The medical device is intended to reduce functional limitations, relieve pain, and consequently improve quality of life.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e2. Indications\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIndicated for patients with symptomatic femorotibial knee osteoarthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e3. Description\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product consists of a sterile, isotonic, viscoelastic solution for intra-articular use and is supplied in a prefilled syringe. Each prefilled syringe contains 2 ml of the viscoelastic solution. 1 ml of the product contains: 10 mg (1%) sodium hyaluronate as well as sodium chloride, sodium monohydrogen phosphate, citric acid, and water for injection purposes. The product is supplied sterile and is intended for single use only. The product is steam sterilized in its blister packaging. No ingredients or raw materials of animal origin are used in the manufacture of the product. The product contains no medicinal active substances.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e4. Method of Administration and Dosage\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRemove the prefilled syringe from the blister and carefully unscrew the rubber cap from the Luer-Lock connector. For intra-articular injections, a 21G cannula is recommended. Attach the cannula to the Luer-Lock connector and lock it with a slight twist. Hold the syringe during administration as shown in Figure 1. It is recommended to administer three injections of 2 ml of the product per knee at weekly intervals. Both knee joints can be treated simultaneously, and treatment cycles of up to 3 injections can be repeated. To avoid intra-articular infections, the injection must be performed under strict aseptic conditions. It is recommended to apply an ice pack to the treated joint for 5–10 minutes after application to prevent pain, swelling, and bleeding.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5. Properties and Mode of Action\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn patients with degenerative joint disease (osteoarthritis), the viscoelasticity of the synovial fluid is significantly impaired. Mechanical \u003c\/span\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003estress on the joint leads to the breakdown of joint cartilage, which in turn causes restricted joint mobility and pain. The lubricating properties of this product contribute to pain reduction and improved joint mobility. The effect of the product lasts up to 6 months after a treatment cycle of 3 intra-articular injections.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003e6. Contraindications and Possible Interactions\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used in the following patients:\u003cbr\u003ePatients with hemochromatosis, ochronosis, or hemophilia \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with Paget's disease of bone, chondromatosis, or pigmented villonodular synovitis \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with inflammatory, infectious, or metabolic arthritis (rheumatoid arthritis, ankylosing spondylitis, soft tissue rheumatism...) \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with a history of coagulation disorders or on anticoagulant therapy \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with known allergy to the product or any of its components \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients requiring permanent or intermittent steroid therapy \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with immunodeficiency or with severe or progressive disease (cardiac, pulmonary, hepatic, renal, hematological, neoplastic, or infectious disease) \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with venous stasis or lymphostasis in the target limb \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with skin diseases or infections at the injection site \u003c\/span\u003e\u003cspan\u003e| \u003c\/span\u003e\u003cspan\u003ePatients with a severe acute or chronic illness for which the use of the product is contraindicated or poses an additional risk according to the physician's assessment\u003cbr\u003eCurrently, no information is available on undesirable interactions with other intra-articularly administered therapies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e7. Side Effects and Adverse Events\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe physician must inform the patient about potential side effects and\/or incompatibilities related to the use of this product, which may occur immediately or some time after the injection. After application, local symptoms may occur in the treated joint (pain, warmth, redness, and swelling). In connection with comparable products, the following adverse events have been reported: mild to moderate joint pain, rarely skin rash, pseudo-septic joint effusions, pruritus, and muscle cramps. In very rare cases, the following adverse events have also been observed: allergic reactions, anaphylactic shock, hemarthrosis, phlebitis, severe acute inflammatory reactions (SAIR), nasopharyngitis, joint stiffness, tendinitis, bursitis, fever, myalgia, and septic arthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe physician must advise the patient to seek medical advice promptly in the event of such an adverse event. Such side effects must be treated appropriately. Adverse reactions related to the injection of the product must be reported to the marketing authorization holder and\/or the manufacturer.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003e8. Warnings\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product must only be administered by physicians trained in intra-articular injection techniques. They should also be familiar with all immunological and other risks that may be associated with the use of biological materials. The product must not be used in pregnant or breastfeeding women or in patients under 18 years of age, as no clinical data are available for these groups.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKeep the product out of sight and reach of children. The product is intended for single use only; the syringe must never be resterilized. Reuse of the product carries a potential infection risk for patients and users. Do not use if the blister packaging is opened and\/or damaged. Do not use any syringe whose protective cap in the blister pack is opened or displaced. Do not use after the expiration date. Patients should be advised to rest the treated joints for 24 hours after each injection (but not immobilize completely) to avoid overuse. Dispose of the syringe, product residues, and cannula after use in a designated container. A 21G cannula is recommended for injection of the product. Compatibility of other needles\/cannulas with the product and syringe has not been tested.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e9. Storage\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStore the product at room temperature (2–25 °C\/36–77 °F) and protect from frost and moisture.\u003cbr\u003eAvailable pack sizes: 1 or 5 prefilled syringes\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003e10. Last Revision\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e2020-01 Version number: Z07\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Recordati Pharma GmbH","offers":[{"title":"Default Title","offer_id":47355880571220,"sku":"131","price":22.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/recosyn-20-recordati-pharma-gmbh-gelenkspritzen-stakonmed-263726.jpg?v=1772215288"},{"product_id":"recosyn-forte-n-44-1-x-2-ml","title":"Recosyn forte N 44 1x 2.0 ml","description":"\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/stakonmed.de\/collections\/recosyn\" title=\"Recosyn | Gelenkspritzen | StakonMed\"\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003c\/a\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eforte N\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSodium hyaluronate intra-articular\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDescription\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product contains a prefilled syringe with hydrogel made from highly purified sodium hyaluronate obtained by bacterial fermentation without genetic modification, with high molecular weight, used to improve viscosity in intra-articular connective tissue. It has undergone steam sterilization for injectable products and is non-pyrogenic.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product contains 1 ml aqueous, physiological phosphate buffer solution with 22 mg sodium\u003c\/span\u003e\u003cspan\u003ehyaluronate. The sodium hyaluronate hydrogel is in a weak, sterile\u003c\/span\u003e\u003cspan\u003elen, isotonic and apyrogenic phosphate-buffered saline solution with a pH of 7.2 (6.8 – 7.4) in sufficient volume for injection. The fill volume of a prefilled syringe is 2 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe chemical components are listed in the table on the right (weight per volume as mg substance per 1 ml hydrogel).\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eProperties and mode of action\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eAn essential component of healthy synovial fluid is the widespread glycosami\u003c\/span\u003e\u003cspan\u003enoglycan hyaluronic acid. This natural biopolymer provides viscoelasticity and, thanks to its lubricating and shock-absorbing properties, enables pain-free physiological movements; it also supplies nutrients to the cartilage. The \u003c\/span\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eforte N \u003c\/span\u003e\u003cspan\u003econtained sodium hyaluronate is a salt of hyaluronic acid.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eIndications\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003ePain and limitation of joint mobility in degenerative changes of the knee joint and other synovial joints, including osteoarthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eContraindications\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used in patients\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with known hypersensitivity to any of the components\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with inflammation in the joint\u003cbr\u003e- with septic arthritis\u003cbr\u003e- with skin infections or skin diseases in the injection area\u003cbr\u003e- with natural or medication-induced coagulation disorders such as hemophilia\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eor when using anticoagulants such as Marcumar (phenprocoumon) or Coumadin (warfarin)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSince there are no clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, use in these patients is not recommended.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePrecautions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eSince septic arthritis can be a serious complication of the treatment, please observe all precautions usually necessary for surgical procedures. Injections of the hydrogel must be administered precisely into the joint cavity; injections into blood vessels and surrounding tissue must be avoided.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use if the prefilled syringe or sterile packaging is damaged.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe opened product must not be resterilized, resealed, or reused. It is intended for use by a single patient at a single application session.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePossible side effects\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo adverse effects were observed in biocompatibility tests with the product. Local reactions such as pain, redness, warmth, and swelling may occur in the treated joint. These symptoms can be reduced by cooling the treated area with an ice pack for 5 to 10 minutes after injection. During the first days of treatment, the simultaneous oral intake of pain and anti-inflammatory medications (NSAIDs) may be beneficial. Treatment should be discontinued in case of severe pain or inflammation. Management of adverse reactions should only be carried out under the supervision of the treating physician. Immediately after the injection, strenuous physical activity should be avoided, and other instructions from the doctor should be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMedical professionals should inform the patient\u003cbr\u003e- about possible adverse events related to the product.\u003cbr\u003e- that the patient must inform a doctor of any adverse event or complication.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePharmacological and chemical interactions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSo far, there are no data on the incompatibility of the product with other solutions for intra-articular use.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThere is a chemical incompatibility between sodium hyaluronate and quaternary ammonium compounds such as benzalkonium chloride, which can lead to crystalline precipitation. Therefore, this product must never come into contact with surgical instruments or other products containing these compounds, or with solutions rinsed with quaternary ammonium compounds as biocidal preservatives.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRemove the prefilled syringe from its packaging. Remove the protective cap from the Luer-Lock thread. Screw a suitable sterile injection needle onto the syringe. The use of a single-use needle is recommended. Air should be evacuated from the needle before injection. The skin area intended for injection must be cleaned with an appropriate topical antiseptic. In the case of joint effusion, it is recommended to first reduce the effusion by aspiration before injecting the gel and to examine it for bacterial etiology. The hydrogel can be injected intraarticularly 1 to 5 times (usually 3) at intervals determined by the physician. The beneficial effects of a treatment last at least 6 months. Treatment cycles can be repeated if necessary.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnused product must be disposed of.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage, method, and duration of application\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage form\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eA box containing one prefilled syringe of 2 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eShelf life\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used after the expiration date. The expiration date (month\/year) is printed on the syringe blister and on the carton.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eStorage instructions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan\u003eThe product should be stored dry between 2° and 25°C and protected from light and impact in the original packaging. Accordingly, warning symbols on the packaging must be observed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKeep the product out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eRecommended user group\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for use by physicians.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv title=\"Page 1\" class=\"page\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eFor single use only. Do not resterilize. Do not use syringes, needles, or hydrogel from open or damaged packaging or attempt to reseal packaging. Syringe contents are non-toxic and non-flammable.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhen using a product from damaged packaging or reusing it on other patients or the same patient at a different time, the intended properties and sterility are not guaranteed. Otherwise possible \u003c\/span\u003e\u003cspan\u003eTransmission of material contamination and pathogens from the environment, the clini- \u003c\/span\u003e\u003cspan\u003ein the patient area or (other) patients could lead to health complications. Resealing or resterilization does not constitute an allowed or guaranteed restoration of usability.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnused syringes and their contents are not infectious and can be disposed of before or after the expiration date, observing national and local regulations. Used syringes and needles must be treated as epidemiologically hazardous waste and national and local regulations for safe use and disposal must be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStatus of information 06\/2021\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Recordati Pharma GmbH","offers":[{"title":"Default Title","offer_id":47355880603988,"sku":"132","price":48.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/recosyn-forte-n-44-recordati-pharma-gmbh-gelenkspritzen-stakonmed-710157.jpg?v=1772215311"},{"product_id":"recosyn-uno-ultra-1-x-4-8-ml","title":"Recosyn Uno Ultra 1x 4.8 ml","description":"\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/stakonmed.de\/collections\/recosyn\" title=\"Recosyn | Gelenkspritzen | StakonMed\"\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003c\/a\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eUno ultra\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSodium hyaluronate intra-articular\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDescription\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product contains a prefilled syringe with hydrogel made from highly purified sodium hyaluronate obtained by bacterial fermentation without genetic modification, with high molecular weight, used to improve viscosity in intra-articular connective tissue. It has undergone steam sterilization for injectable products and is non-pyrogenic.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product contains 1 ml aqueous, physiological phosphate buffer solution with 25 mg Na\u003c\/span\u003e\u003cspan\u003etriumhyaluronate. The sodium hyaluronate hydrogel is in a weak, \u003c\/span\u003e\u003cspan\u003esterile, isotonic, and apyrogenic phosphate-buffered saline solution with a pH of 7.2 (6.8 – 7.4) in sufficient volume for injection. The fill volume of a prefilled syringe is 4.8 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe chemical components are listed in the table on the right (weight per volume as mg substance per 1 ml hydrogel).\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eProperties and mode of action\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eAn essential component of healthy synovial fluid is the widespread glycosami\u003c\/span\u003e\u003cspan\u003enoglycan hyaluronic acid. This natural biopolymer provides viscoelasticity and, thanks to its lubricating and shock-absorbing properties, enables pain-free physiological movements; it also supplies nutrients to the cartilage. The \u003c\/span\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eUno ultra \u003c\/span\u003e\u003cspan\u003eThe contained sodium hyaluronate is a salt of hyaluronic acid.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eIndications\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePain and limitation of joint mobility in degenerative changes of the knee joint and other synovial joints, including osteoarthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eContraindications\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used in patients\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with known hypersensitivity to any of the components\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with inflammation in the joint\u003cbr\u003e- with septic arthritis\u003cbr\u003e- with skin infections or skin diseases in the injection area\u003cbr\u003e- in cases of natural or medication-induced coagulation disorders such as hemophilia\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eor when using anticoagulants such as Marcumar (phenprocoumon) or Coumadin (warfarin)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSince there are no clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, use in these patients is not recommended.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePrecautions\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSince septic arthritis can be a serious complication of the treatment, please observe all precautions usually necessary for surgical procedures. Injections of the hydrogel must be administered precisely into the joint cavity; injections into blood vessels and surrounding tissue must be avoided.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use if the prefilled syringe or sterile packaging is damaged.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe opened product must not be resterilized, resealed, or reused. It is intended for use by a single patient at a single treatment session.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePossible side effects\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo adverse effects were observed in biocompatibility tests with the product. Local reactions such as pain, redness, warmth, and swelling may occur in the treated joint. These symptoms can be reduced by applying an ice pack to the treated area for 5 to 10 minutes after injection. During the first days of treatment, the simultaneous oral intake of pain and anti-inflammatory medications (NSAIDs) may be beneficial. Treatment should be discontinued in case of severe pain or inflammation. Management of adverse reactions should only be carried out under the supervision of the treating physician. Immediately after the injection, strenuous physical activity should be avoided and other instructions from the physician should be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMedical professionals should inform the patient\u003cbr\u003e- about possible adverse events related to the product.\u003cbr\u003e- that the patient must report any adverse event or complication to a doctor.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePharmacological and chemical interactions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSo far, there are no data on the incompatibility of the product with other solutions for intra-articular use.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThere is a chemical incompatibility between sodium hyaluronate and quaternary ammonium compounds such as benzalkonium chloride, which can lead to crystalline precipitation. Therefore, this product must never come into contact with surgical instruments or other products containing these compounds or rinsed with solutions containing quaternary ammonium compounds as biocidal preservatives.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage, type, and duration of use\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eRemove the prefilled syringe from its packaging. Remove the protective cap from the Luer-lock thread. Screw a suitable sterile injection needle onto the syringe. The use of a single-use needle is recommended. Air should be evacuated from the needle before injection. The skin area intended for injection must be cleaned with an appropriate topical antiseptic. In the case of joint effusion, it is recommended to first reduce the effusion by aspiration before injecting the gel and to examine it for bacterial etiology. The hydrogel can be injected intra-articularly once. The beneficial effects of a treatment last at least 6 months. Treatment cycles can be repeated if necessary.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnused product must be disposed of.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage form\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eA box with one prefilled syringe of 4.8 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDurability\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used after the expiration date. The expiration date (month\/year) is printed on the syringe blister and on the carton.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStorage instructions\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product should be stored dry between 2° and 25°C and protected from light and impact in the original packaging. Accordingly, warning symbols on the packaging must be observed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKeep the product out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eRecommended user group\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for use by physicians.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eFor single use only. Do not resterilize. Do not use syringes, needles, or hydrogel from open or damaged packaging or attempt to reseal packaging. Syringe contents are non-toxic and non-flammable.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eWhen using a product from damaged packaging or reusing it on other patients or the same patient at a different time, the intended properties and sterility are not guaranteed. Otherwise possible \u003c\/span\u003e\u003cspan\u003eTransmission of material contamination and pathogens from the environment, the clinical\u003c\/span\u003e\u003cspan\u003ein the area or (other) patients could lead to health complications. Resealing or resterilization does not constitute an allowed or guaranteed restoration of the usable condition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUnused syringes and their contents are not infectious and can be disposed of before or after the expiration date, observing national and local regulations. Used syringes and needles must be treated as epidemiologically hazardous waste and national and local regulations for safe use and disposal must be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInformation status 06\/2021\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Recordati Pharma GmbH","offers":[{"title":"Default Title","offer_id":47355880964436,"sku":"133","price":134.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/recosyn-uno-ultra-recordati-pharma-gmbh-gelenkspritzen-stakonmed-680224.jpg?v=1772215382"},{"product_id":"recosyn-max-forte-n-1-x-2-ml","title":"Recosyn Max forte N 1x 2.0 ml","description":"\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/stakonmed.de\/collections\/recosyn\" title=\"Recosyn | Gelenkspritzen | StakonMed\"\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003c\/a\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eMax forte N\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSodium hyaluronate intra-articular plus niacinamide\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDescription\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe prefilled syringe contains a hydrogel made of high-molecular and highly purified sodium hyaluronate from bacterial fermentation. The product serves to improve viscosity in the intra-articular connective tissue. It has undergone steam sterilization for injectable products and is non-pyrogenic.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eMax forte N \u003c\/span\u003e\u003cspan\u003econtains 2 ml aqueous, physiological phosphate buffer solution with \u003c\/span\u003e\u003cspan\u003e44 mg sodium hyaluronate. The sodium hyaluronate hydrogel is contained in \u003c\/span\u003e\u003cspan\u003ea weak, sterile, isotonic, and apyrogenic phosphate-buffered saline solution with a pH of 7.2 (6.8 – 7.4) in sufficient volume for injection. The fill volume is 2 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe chemical components are listed in the table (weight per volume as mg substance per 1 ml hydrogel):\u003cbr\u003e(a) Sodium hyaluronate, (b) Sodium chloride, (c) Disodium hydrogen phosphate 2 H\u003c\/span\u003e\u003cspan\u003e2\u003c\/span\u003e\u003cspan\u003eO,\u003cbr\u003e(d) Sodium dihydrogen phosphate 2 H\u003c\/span\u003e\u003cspan\u003e2\u003c\/span\u003e\u003cspan\u003eO, (e) Water for injection, (f) Niacinamide\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eProperties and mode of action\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eHyaluronic acid, a widespread glycosaminoglycan, is an essential component \u003c\/span\u003e\u003cspan\u003ehealthy synovial fluid. This natural biopolymer provides viscoelasticity and\u003c\/span\u003e\u003cspan\u003eenables pain-free physiological movements thanks to its lubricating, shock-absorbing properties. Additionally, it supplies nutrients to the cartilage. The \u003c\/span\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eMax forte N \u003c\/span\u003e\u003cspan\u003econtained sodium hyaluronate is a salt of hyaluronic acid.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eIndications\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePain and limitation of joint mobility in degenerative changes of the knee joint and other synovial joints, including osteoarthritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eContraindications\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used in patients\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with known hypersensitivity to any of the components.\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003e- with inflammation in the joint.\u003cbr\u003e- with septic arthritis.\u003cbr\u003e- with skin infections or skin diseases in the injection area.\u003cbr\u003e- with natural or medication-induced coagulation disorders such as hemophilia or when using anticoagulants like Marcumar (phenprocoumon) or Coumadin (warfarin).\u003cbr\u003eSince there are no clinical data on the use of hyaluronic acid in children, pregnant or breastfeeding women, use in these patients is not recommended.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePrecautions\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSince septic arthritis can be a serious complication of the treatment, please observe all precautions usually necessary for surgical procedures. Injections of the hydrogel must be administered directly into the joint cavity; injections into blood vessels and surrounding tissue must be avoided.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDo not use if the prefilled syringe or sterile packaging is damaged.\u003cbr\u003eThe opened product must not be resterilized, resealed, or reused. It is intended for use by a single patient at a single application session.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePossible side effects\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eNo adverse side effects were observed in biocompatibility tests with the product. Local reactions such as pain, redness, warmth, and swelling may occur at the treated joint. These reactions can be reduced by cooling the treated area with an ice pack for 5 to 10 minutes after the injection. During the first days of treatment, the simultaneous oral intake of pain and anti-inflammatory medications (NSAIDs) may be beneficial. Treatment should be discontinued in case of severe pain or inflammation. Management of adverse reactions should only be carried out under the supervision of the treating physician. Immediately after the injection, strenuous physical activity should be avoided and other instructions from the doctor followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eMedical personnel inform the patient about possible adverse events related to the product and advise that any side effect or complication must be reported to a doctor immediately.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003ePharmacological and chemical interactions\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eSo far, there are no data on the incompatibility of the product with other solutions for intra-articular use.\u003cbr\u003eThere is a chemical incompatibility between sodium hyaluronate and quaternary ammonium compounds such as benzalkonium chloride, which can lead to crystalline precipitation. Therefore, this product must never come into contact with surgical instruments or other products that contain these or have been rinsed with solutions containing quaternary ammonium compounds as biocidal preservatives.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage, type, and duration of use\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe prefilled syringe is to be removed from its packaging. The protective cap is to be removed from the Luer-Lock thread and a suitable sterile injection needle screwed onto the syringe. The use of a single-use needle is recommended. Air should be evacuated from the needle before injection. The skin area intended for injection must be cleaned with an appropriate topical antiseptic. In the case of joint effusion, it is recommended before the injection of \u003c\/span\u003e\u003cspan\u003eRecosyn\u003c\/span\u003e\u003cspan\u003e® \u003c\/span\u003e\u003cspan\u003eMax forte N \u003c\/span\u003e\u003cspan\u003efirst reduce the effusion by aspiration and examine it for bacterial etiology. The hydrogel can be injected intraarticularly 1 to 5 times at intervals determined by the physician. The beneficial effects of a treatment last at least 6 months. Treatment cycles can be repeated if necessary.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDepending on the fill volume, multiple joints of a patient can be treated simultaneously. Unused product must be disposed of.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eDosage form\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eA box containing one prefilled syringe of 2 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eShelf life\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product must not be used after the expiration date. The expiration date (month\/year) is printed on the syringe blister and on the box.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eStorage instructions\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"page\" title=\"Page 1\"\u003e\n\u003cdiv class=\"section\"\u003e\n\u003cdiv class=\"layoutArea\"\u003e\n\u003cdiv class=\"column\"\u003e\n\u003cp\u003e\u003cspan\u003eThe product should be stored dry between 2° and 25°C, protected from light and impact, in the original packaging. Accordingly, observe the warning symbols on the packaging.\u003cbr\u003eKeep the product out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRecommended user group\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for use by physicians.\u003cbr\u003eFor single use only. Do not resterilize. Do not use or attempt to reseal syringes, needles, and hydrogel from open or damaged packaging.\u003cbr\u003eSyringe contents are non-toxic and non-flammable.\u003cbr\u003eUsing a product from damaged packaging or reusing it on other patients or the same patient at a different time does not guarantee the intended properties and sterility. Otherwise, it can\u003c\/span\u003e\u003cspan\u003ea possible transmission of material contamination and pathogens from the \u003c\/span\u003e\u003cspan\u003eEnvironment, the clinical area, or (other) patients may suffer health complications. Resealing or resterilizing does not constitute an allowed or guaranteed restoration of the usable condition.\u003cbr\u003eUnused syringes and their contents are not infectious and can be disposed of before or after the expiration date, observing national and local regulations. Used syringes and needles must be treated as epidemiologically hazardous waste, and national and local regulations for safe use and disposal must be followed.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003erev. 03\/2022-V02 rec\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Recordati Pharma GmbH","offers":[{"title":"Default Title","offer_id":47355880997204,"sku":"134","price":94.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/recosyn-max-forte-n-recordati-pharma-gmbh-gelenkspritzen-stakonmed-544861.jpg?v=1772215337"}],"url":"https:\/\/stakonmed.at\/en\/collections\/recosyn.oembed","provider":"StakonMed","version":"1.0","type":"link"}